AGP Executive Report
Last update: 8 hours agoDrug Safety Follow-Through: A U.S. FDA review of Tavneos shows how “postmarket” safety studies can lag badly—only 21 of 300 planned patients enrolled—while liver injury cases linked to the drug are already being tracked. Public Health Progress: WHO has certified Timor-Leste as having eliminated trachoma as a public health problem, meaning the whole WHO South-East Asia region is now trachoma-free. Regional Health Systems: The WHO South-East Asia committee adopted the Dili Declaration, pushing Universal Health Coverage, stronger health workforce equity, and steps on devices, diagnostics, assistive tech, TB, and vaccine confidence. Care Access Abroad: IHH Healthcare Malaysia signed an MoU with Timor-Leste to set up specialist referral pathways for National Parliament personnel, including travel and repatriation support if needed. Emergency Response: Davao City broke ground on a “Central 911” satellite station to cut ambulance and rescue response times for remote communities.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
